Results 201 to 210 of about 11,302 (215)

Placental expression of syndecan 1 is diminished in preeclampsia

American Journal of Obstetrics and Gynecology, 2000
Syndecan 1 is a cell surface heparan sulfate proteoglycan that binds growth factors and antithrombin III. The objective of this study was to examine whether placental expression of syndecan 1 in preeclampsia differs from that in normal pregnancy and whether gestational age and fetal growth affect syndecan 1 expression.An immunohistochemical analysis of
Harry Kujari, Pirjo L.K. Inki, V. Jokimaa, Leena Anttila, Eeva Ekholm   +4 more
openaire   +3 more sources

Role of Syndecan-1 in Cancer Stem Cells

2021
Syndecan-1 (CD138) is a cell surface heparan sulfate proteoglycan that is frequently misexpressed in cancer. Under physiological conditions, it is involved in the regulation of processes as diverse as leukocyte recruitment, wound repair, angiogenesis, exosome formation and epithelial-to-mesenchymal transition. Apart from a role as adhesion molecule and
Sherif AbelAziz Ibrahim, Hebatallah Hassan, Rolland Reinbold, Nancy Adriana EspinozaSanchez, Burkhard Greve, Martin Götte   +5 more
openaire   +3 more sources

Syndecan-1 expression in laryngeal cancer

European Archives of Oto-Rhino-Laryngology, 2002
Syndecan-1 is a member of the syndecan family of cell surface heparan sulphate proteoglycans. The aim of this study was the evaluation of syndecan-1 expression in laryngeal cancer. The findings were correlated both with the clinico-pathological parameters of the tumours and with patient survival.
openaire   +3 more sources

Altered expression of syndecan‐1 in prostate cancer

APMIS, 2004
Syndecan‐1 is a cell surface heparan sulfate proteoglycan expressed by epithelial cells. It interacts with growth factors, matrix components, and other extracellular proteins, and is thought to be involved in processes such as cell growth, differentiation and adhesion. The expression of syndecan‐1 appears generally downregulated in human carcinomas and
Markku Salmivirta, Markku Salmivirta, Markku Jalkanen, Markku Kallajoki, Iina Kujala, Johanna Kiviniemi, Marja-Terttu Matikainen, Kalle Alanen   +7 more
openaire   +3 more sources

Expression of syndecan-1 in human placenta and decidua

Placenta, 1998
Syndecan-1 is a cell surface heparan sulphate proteoglycan, which binds to the extracellular matrix (ECM), growth factors and antithrombin III. The early expression of syndecan-1 during mouse embryonic development suggests a potential role in the communication between the embryo and the ECM of decidua.
L. Anttila, Harry Kujari, V. Jokimaa, O. Hirvonen, Eeva Ekholm, P. Inki   +5 more
openaire   +3 more sources

Syndecan-1: a key player in health and disease

Immunogenetics
Syndecan-1 (SDC-1) is a transmembrane protein localized on the basolateral surface of epithelial cells, encompassing a core protein with heparin sulfate and chondroitin sulfate glycosaminoglycan side chains. SDC-1 is involved in a panoply of cellular mechanisms including cell-to-cell adhesion, extracellular matrix interactions, cell cycle modulation ...
Lara, Diab, Sahar, Al Kattar, Naim, Oueini, Jihad, Hawi, Antoine, Chrabieh, Laura, Dosh, Rosalyn, Jurjus, Angelo, Leone, Abdo, Jurjus   +8 more
openaire   +2 more sources

Syndecan-1

2017
Niharika Swain, Rashmi Maruti Hosalkar, Samapika Routray   +2 more
openaire   +1 more source

Syndecan-1

2000
Clare M. Isacke, Michael A. Horton
openaire   +2 more sources

Syndecan-1 is a novel regulator of angiogenesis

Experimental and Clinical Endocrinology & Diabetes, 2005
K Elenius, Robert R. Greb, Ludwig Kiesel, P. Wülfing, V Elenius, L. Rossi, AM Joussen, Dorothe Spillmann, Martin Götte   +8 more
openaire   +2 more sources

Syndecan-1 is overexpressed during atherogenesis

Atherosclerosis, 2015
B. Richard, S. Vo, N. Charnaux
openaire   +2 more sources